Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice

Pathology & Oncology Research(2024)10.3389/pore.2024.1611826Source: DataRank Database

Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice is a research paper published in Pathology & Oncology Research (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Nilay Bakoglu,Emine Cesmecioglu ORCID,Matthew G Hanna,Fresia Pareja ORCID,Hannah Y. Wen ORCID

Live enrichment

PubMed:39267995 PMC:PMC11390455 OpenAlex:https://openalex.org/W4402019215

NCI NIH HHS

Grant: P50 CA247749

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611826/pdf

GOLDhttps://doi.org/10.3389/pore.2024.1611826

publisherhttps://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611826/pdf

publisherhttps://www.por-journal.com/articles/10.3389/pore.2024.1611826/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39267995

Fields of Study

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchNanofabrication and Lithography TechniquesMedicine0301 basic medicine03 medical and health sciences0302 clinical medicineHumansFemaleErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsImmunohistochemistryBiomarkers, TumorIn Situ Hybridization, FluorescenceImage Processing, Computer-AssistedCarcinoma, Ductal, BreastPrognosis

MeSH Terms

Breast NeoplasmsFemaleHumansImage Processing, Computer-AssistedImmunohistochemistryPrognosisBiomarkers, TumorIn Situ Hybridization, FluorescenceCarcinoma, Ductal, BreastReceptor, ErbB-2Erb-b2 Receptor Tyrosine Kinases

Keywords

ImmunohistochemistryConcordanceMedicineHuman Epidermal Growth Factor Receptor 2Breast carcinomaPathologyBreast cancerOncologyInternal medicineCancerHer2Whole Slide ImagingSemi-automated AnalysisCarcinoma, Ductal, BreastNeoplasms. Tumors. Oncology. Including cancer and carcinogensPathology and Oncology ArchiveBreast NeoplasmsPrognosisErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorImage Processing, Computer-AssistedRB1-214HumansFemaleRC254-282In Situ Hybridization, Fluorescence

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)